UNITY BIOTECHNOLOGY INC - COM (UBX)

CUSIP: 91381U101

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
20,897,716
Share change
+709,022
Total reported value
$109,503,899
Put/Call ratio
112%
Price per share
$5.24
Number of holders
78
Value change
+$5,094,226
Number of buys
47
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 91381U101?
CUSIP 91381U101 identifies UBX - UNITY BIOTECHNOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY INC - COM (UBX) as of Q4 2020

As of 31 Dec 2020, UNITY BIOTECHNOLOGY INC - COM (UBX) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,897,716 shares. The largest 10 holders included FMR LLC, BAILLIE GIFFORD & CO, BlackRock Inc., VANGUARD GROUP INC, Mayo Clinic, Invus Financial Advisors, LLC, STATE STREET CORP, Founders Fund V Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY. This page lists 78 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.